EmilyLiffickMD
Psychiatry • Indianapolis, INAttending Physician, Providence St. Patrick Hospital; Adjunct Professor, Psychiatry, Indiana University School of Medicine
Dr. Liffick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1111 W 10th St
# Psychiat
Indianapolis, IN 46202Phone+1 317-274-1224Fax+1 317-880-8498
Education & Training
Indiana University School of Medicine (Indianapolis)Residency, Psychiatry, 2005 - 2009- Indiana University School of MedicineClass of 2005
Certifications & Licensure
IN State Medical License 2008 - 2025
MT State Medical License 2015 - 2025
KY State Medical License 2014 - 2024
AK State Medical License 2014 - 2022
ID State Medical License 2014 - 2022
NE State Medical License 2014 - 2022- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) Start of enrollment: 2010 Sep 01
- The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia Start of enrollment: 2011 May 01
- Fingolimod in Schizophrenia Patients Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsEffects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia.Michael M. Francis, Tom A. Hummer, Emily Liffick, Jenifer L. Vohs, Nikki Mehdiyoun
Brain Imaging and Behavior. 2021-08-01 - 21 citationsAbuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo- and Alprazolam-Controlled Crossover Study.Darren Wilbraham, Paul Berg, Max Tsai, Emily Liffick, Li Shen Loo
Journal of Clinical Pharmacology. 2020-04-01 - 7 citationsAssessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat.Brian A. Willis, Scott W. Andersen, Mosun Ayan-Oshodi, Douglas E. James, Emily Liffick
Journal of Clinical Pharmacology. 2020-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
